“Hyperuricaemia / gout risk”的搜索结果，显示 431-440 项，共有 11095 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 放射科- 临床试验- 妙佑医疗国际

   In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of the coronary anatomy ...

3. 心血管医学- 临床试验- 妙佑医疗国际

   ... risk factors, treatment and outcomes. Our objective is to prospectively ... In addition to exploring ED treatment patterns and success of both ischemic and ...

4. 放射科- 临床试验- 妙佑医疗国际

   In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of the coronary anatomy ...

5. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

6. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...

7. 假性痛风- 诊断与治疗- 妙佑医疗国际

   这种疾病类似于痛风，会引起一个或多个关节突然疼痛肿胀。治疗可以减轻疼痛，改善关节功能。

8. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...

9. 血液科- 临床试验- 妙佑医疗国际

   ... risk for developing CRCT identified prior to the onset of therapy. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell ...

10. 血液科- 临床试验- 妙佑医疗国际

    Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring ...